Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02140242
What this trial is testing

Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

Who this might be right for
Leukemia, Myelocytic, Acute
Technische Universität Dresden 721
Early research (Phase 1)Study completedNCT02270788
What this trial is testing

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 10
Testing effectiveness (Phase 2)UnknownNCT00887042
What this trial is testing

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

Who this might be right for
Acute Myeloid Leukemia
The Korean Society of Pediatric Hematology Oncology 35
Early research (Phase 1)UnknownNCT01280786
What this trial is testing

Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Synta Pharmaceuticals Corp. 36
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)UnknownNCT04174586
What this trial is testing

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

Who this might be right for
Safety IssuesEfficiency
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT04827719
What this trial is testing

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 38
Not applicableUnknownNCT02172365
What this trial is testing

Allogeneic SCT for CML, TKI Failure After TKI Failure

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 350
Not applicableStudy completedNCT01034839
What this trial is testing

High-dose Cytarabine and Survival in AML

Who this might be right for
Acute Myeloid Leukemia
University of Sao Paulo General Hospital 499
Post-approval studies (Phase 4)UnknownNCT00180128
What this trial is testing

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia, Promyelocytic, Acute
Technische Universität Dresden 80
Testing effectiveness (Phase 2)UnknownNCT02809092
What this trial is testing

Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hospital de Clinicas de Porto Alegre 30
Testing effectiveness (Phase 2)Study completedNCT00062075
What this trial is testing

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
National Cancer Institute (NCI) 47
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)UnknownNCT03913312
What this trial is testing

Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Ruijin Hospital 150
Testing effectiveness (Phase 2)Study completedNCT02464657
What this trial is testing

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00167219
What this trial is testing

Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

Who this might be right for
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota 15
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006475
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Who this might be right for
Leukemia
Novartis
Next Page